Feasibility & site selection for CROs

Send us your next protocol. The first one is free.

Your sponsor has heard the same feasibility story before. Walk into the bid defense with one they cannot argue with: the investigators who have enrolled trials like this one and the patients they treat, counted from real data. Finished by our team in days.

For CROs new to Quantum. One protocol, no obligation. How it works

Bid defense · the question● in the room
Sponsor

Every other CROinferred
  • Historical site performance
  • The site questionnaire
  • A therapeutic-area average
The story the sponsor heard this morning.
You, with Quantumcounted
  1. S‑04PI, 0 trials like this0 pts
  2. S‑11PI, 0 trials like this0 pts
  3. S‑07PI, 0 trials like this0 pts
Patients they actually treat, counted.
Finished in daysEvery line countedYour templateReady for the room
Illustrative. No real sponsor, protocol or site data shown.
The question

So how do you make your bid more defensible?

Not with a slicker deck or a longer site list. With an answer the sponsor can’t get from the CRO sitting across from you.

The answer

Your bid defense pack, and every line counted.

The investigators who have actually enrolled trials like this one. The patients they actually treat, counted from real data, not inferred from registries and questionnaires. The reasoning behind every rank. Our team finishes it in days, in your own template, so you are not presenting another site list. You are showing the sponsor why your plan will enroll.

The opportunity

Everyone’s fighting over the obvious sites. Where are the patients they’re missing?

The whole industry crowds the same marquee centers, because that’s where the volume and the KOLs are obvious. We find the qualifying patients sitting in less-contested sites nobody has pitched yet — sometimes with more confidence than the crowded ones.

Where everyone goes

The same marquee academic centers, over and over. Contested, expensive, and slow to enroll.

Bids pitching these centers7contested

The sites nobody pitched

Overlooked sites with real qualifying patients, and no one else pitching them.

+ real qualifying patients
Bids pitching these sites0open

Illustrative. Your competitors are all bidding the same crowded sites. The advantage is the patients they can’t see.

Why it holds up

Real data. Not inferred.

This only works because the data underneath is real — the whole patient journey across every U.S. institution, not the partial snapshot everyone else builds on. So when the sponsor asks how you know these sites will enroll, you have a number, not an estimate. You don’t need to walk them through the math; you need them to believe it, and a real count does that.

What it wins you

A stronger story, a stronger bid.

It compounds, all the way to the award.

01Stronger feasibility storyCounted, not inferred
02Stronger bid defenseA number for every site
03Greater sponsor confidenceThe hardest question, answered first
04You win the workThe award
How it works with us

A forward-deployed team, not another tool to run.

Your feasibility team does not log into anything. You send the protocol, we do the work, and you walk into the room with the evidence. Here is what that looks like on one bid.

Day 0

The RFP lands

You send us the protocol and the inclusion and exclusion criteria. That is the whole handoff.

You: forward one document
Days 1 to 3

The feasibility read

How many patients actually qualify, counted from the real patient record, and the candidate sites that can reach them. Enough to build a proposal that says something your competitors cannot.

You: write the bid on a count, not an estimate
Before the meeting

Slides in your template

Every proposed site and investigator, the patients they actually treat, their record on trials like this one, and the reasoning behind each rank. Finished, in your own template.

You: rehearse with the evidence, not around it
The room

The bid defense

When the sponsor asks how you know these sites will enroll, you have a number for each one and the investigator who will do it. That is usually where the conversation changes.

You: answer the hardest question first

Illustrative timeline. Turnaround depends on the protocol; the handoff does not.

New to Quantum

One protocol. Free. Then decide.

If we have not worked together, send us the next protocol you are about to defend. You get back the evidence a proposal needs, in days: the investigators who have enrolled trials like this one, the patients they actually treat, a reason for every site, and slides in your own template. No obligation.

  1. Send it. One protocol, the countries, the defense date. That is all we need.
  2. Get it back in days. Finished, in your template, with the reasoning shown.
  3. Put it in front of your sponsor. It proves itself, or it doesn’t. Then decide.

For CROs new to Quantum. One protocol. Sponsor and site details stay confidential.

Proof

See it on a real study.

In a recent rare-disease program, running the protocol against the actual patient population nearly tripled the eligible pool — then became a ranked, defensible site list the team could take straight into a bid defense.

Questions CROs ask

For CROs, answered.

How does this fit into our RFP and bid defense process?

It sits alongside it. For an RFP, send us the protocol and you get a fast feasibility read to build the proposal on. For the bid defense, you get the full site-by-site answer: qualifying patient counts, named investigators with a measured track record, and the reasoning behind every rank. Your feasibility team stays in charge of the bid. Clinical trial feasibility →

What do we actually get back?

Slides in your own template: the proposed sites, the investigators behind them and their record on trials like this one, the patients each one actually treats, counted from real data, and the reasoning behind every rank. Ready to present in your name.

Is the first protocol really free?

Yes, if we have not worked together. Send us one protocol you are about to defend and our team finishes it the same way as any engagement, in your own template. Take it into the sponsor meeting. If it proves itself, we talk about the next one. If it does not, you owe us nothing. Send us your protocol →

Will the sponsor know we worked with you?

That is your call. The deliverable is yours to present in your own name, and the evidence stands on its own in the room. We stay in the background.

We already have a feasibility team and our own data. Why add you?

Because the data most feasibility teams run on is the same data your competitors run on: registries, past trial counts and site questionnaires, all inferred. We count from the real, patient-level record, so the sponsor hears a different answer from you. Many teams use us as a second set of eyes on a list they have already built. Why patient-level data beats inferred →

How is this different from the trial databases we subscribe to?

Those tell you who has run trials before and who looks strong on paper. They cannot tell you how many patients at a given site actually qualify under this protocol, because they never see the patient record. We answer that question, and we pair it with the investigator’s real enrollment history, so you get both signals on the same site. How the ranking works →

How fast can you turn around a live bid?

Days. Send the protocol or the RFP and we come back with the counted patients, the sites that can reach them, and the reasoning. No software to install and nothing for your team to learn. Send us your protocol →

Put it in front of your sponsor

Send us the protocol you are about to defend.

Our team finishes it in days: slides in your own template, every line counted, ready for the room. New to Quantum? The first one is free.